Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/AVCN stock hub

TSX/AVCN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/AVCNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/AVCN

In the news

Latest news · TSX/AVCN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-26.2

P25 -121.5P50 -40.9P75 0.5

ROIC-16.4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/AVCN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

CAD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	112
Employees Change	25%
Employees Change Percent	28.74
Enterprise value	CAD 25.2M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA05368K1003
Last refreshed	2026-05-10
Market cap	CAD 17M
Price	CAD 0.14
Price currency	CAD
Rev Per Employee	227,488.35x
Sector	Healthcare
Sic	2834
Symbol	tsx/AVCN
Website	https://www.avicanna.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.25%
EV Earnings	-9.15x
EV/FCF	-17.57x
EV/Sales	0.99x
FCF yield	-8.46%
P/B ratio	1.49x
P/S ratio	0.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.92%
EBITDA Margin	-8.8%
Gross margin	53.06%
Gross Profit	CAD 13.5M
Gross Profit Growth	10.87%
Gross Profit Growth Q	32.48%
Gross Profit Growth3 Y	129.71%
Net Income	CAD -2.8M
Net Income Growth Years	5%
Pretax Margin	-10.83%
Profit Margin	-10.83%
Profit Per Employee	CAD -24,636
ROA	-8.55
Roa5y	-22.37
ROCE	-23.06
ROE	-26.17
Roe5y	-135.3
ROIC	-16.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-46.02%
Cagr3y	-33.54%
Cagr5y	-34.15%
EPS Growth Years	5
Revenue Growth	0.08x
Revenue Growth Q	-0.25x
Revenue Growth Years	8x
Revenue Growth3 Y	84.64x
Revenue Growth5 Y	74.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.25
Assets	CAD 21.2M
Cash	CAD 280,630
Current Assets	CAD 7.9M
Current Liabilities	CAD 9.2M
Equity	CAD 11.4M
Interest Coverage	-53.68
Liabilities	CAD 9.9M
Long Term Assets	CAD 13.3M
Long Term Liabilities	CAD 677,519
Net Cash	CAD 280,630
Net Cash By Market Cap	CAD 1.65
Net Cash Growth	-17.17%
Net Debt Equity	CAD -0.02
Tangible Book Value	CAD 1.9M
Tangible Book Value Per Share	CAD 0.02
WACC	6.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.86
Inventory Turnover	3.5
Net Working Capital	CAD -1.6M
Quick ratio	0.42
Working Capital	CAD -1.3M
Working Capital Turnover	CAD -17.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-46%
200-day SMA	0.22
3Y total return	-70.65%
50-day SMA	0.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.61%
All Time High	7.4
All Time High Change	-98.18%
All Time High Date	2019-07-18
All Time Low	0.14
All Time Low Change	0%
All Time Low Date	2026-05-07
ATR	0.01
Beta	0.35
Beta1y	0.69
Beta2y	1.33
Ch YTD	-40
High	0.14
High52	0.31
High52 Date	2025-07-25
High52ch	-56.45%
Low	0.14
Low52	0.14
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-14.88%
Price vs 200-day SMA	-39.41%
RSI	28.86
RSI Monthly	34.3
RSI Weekly	22.63
Sharpe ratio	-0.61x
Sortino ratio	-0.76
Total Return	-14.69%
Tr YTD	-40
Tr1m	-10%
Tr1w	-6.9%
Tr3m	-25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.8M
Operating margin	-10.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109,381,081%
Net Borrowing	-112,686
Shares Insiders	11.27%
Shares Institutions	6.09%
Shares Out	125,791,870
Shares Qo Q	5.17%
Shares Yo Y	14.69%
Short Float	0.13%
Short Shares	0.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -2.6M
Average Volume	157,217x
Bv Per Share	0.02
CAPEX	CAD -255,873
Ch1m	-10
Ch1w	-6.9
Ch1y	-46
Ch3m	-25
Ch3y	-70.65
Ch5y	-87.61
Ch6m	-47.06
Change	0%
Change From Open	0
Close	0.14
Days Gap	0
Depreciation Amortization	539,538
Dollar Volume	8,572.5
Earnings Date	2026-05-12
EBIT	CAD -2.8M
EBITDA	CAD -2.2M
EPS	CAD -0.02
F Score	4
FCF	CAD -1.4M
FCF EV Yield	-5.69x
FCF Per Share	CAD -0.01
Financing CF	963,174
Fiscal Year End	December
Founded	2,016
Goodwill	334,000
Investing CF	-255,842
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Ma150	0.21
Ma150ch	-34.78%
Ma20	0.15
Ma20ch	-7.41%
Net CF	-167,397
Next Earnings Date	2026-05-12
Open	0.14
Position In Range	0
Ppne	12,385,249
Price Date	2026-05-08
Ptbv Ratio	9.02
Relative Volume	0.4x
Revenue	25,478,695x
SBC By Revenue	4.6x
Share Based Comp	1,171,055
Tr6m	-47.06%
Volume	63,500
Z Score	-4.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/AVCN pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/AVCN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/AVCN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.1%

Share of float held by funds and institutions

Insider ownership

+11.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

+0.1%

Float sold short by bearish positioning

Y/Y dilution

+14.7%

Negative means the company is buying back shares.

Technical

TSX/AVCN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.9

Below 30: short-term oversold

Price vs 200-day MA

-39.4%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

-0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/AVCN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/AVCN stock rating?

tsx/AVCN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/AVCN analysis?

The full report lives at /stocks/tsx/AVCN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/AVCN?

The latest report frames tsx/AVCN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/AVCN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.